Sign In
Buy IXJ
$100.26
-0.98 (-0.97%)
At Close: Jul 31, 2026
iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026?
03:30pm, Thursday, 23'rd Jul 2026
iShares Global Healthcare ETF provides broader diversification with 110 holdings compared to 25 positions in VanEck Biotech ETF VanEck Biotech ETF delivered a 30.8% 1-year total return but has experie
Which iShares Healthcare ETF Is the Better Buy: Diversified IXJ or Biotech-Focused IBB?
07:49am, Thursday, 23'rd Jul 2026
IBB delivered 44% returns in one year but swung 40% lower at its worst. IXJ grew steadily with half the volatility and a 1.5% dividend yield.
Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ
11:53pm, Wednesday, 22'nd Jul 2026
The iShares Global Healthcare ETF provides broader exposure with 110 holdings across various sub-sectors compared to the 26 positions in the VanEck Pharmaceutical ETF The VanEck Pharmaceutical ETF fea
PINK vs. IXJ: Which Health Care ETF Is the Better Buy for Investors?
06:45am, Wednesday, 22'nd Jul 2026
PINK has stronger one-year and three-year returns, while IXJ offers lower costs and a higher dividend yield.
Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT?
02:12pm, Tuesday, 21'st Jul 2026
iShares Global Healthcare ETF provides broad exposure to 110 global stocks while First Trust NYSE Arca Biotechnology Index Fund concentrates on 30 biotech positions. iShares Global Healthcare ETF carr
IXJ vs. RSPH: Which Healthcare ETF Is the Better Buy?
01:32pm, Tuesday, 21'st Jul 2026
IXJ offers a higher dividend yield and lower volatility with global exposure, while RSPH's equal-weight approach posted a stronger 1-year return.
For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026?
10:44am, Monday, 20'th Jul 2026
PPH's concentrated 26-stock portfolio delivered 28% returns over one year, while its 2% dividend yield beats IXJ by 50 basis points.
Will the Invesco Pharma ETF or iShares Global Healthcare Fund Be the Better Health Care Fund in 2026?
10:17am, Monday, 20'th Jul 2026
IXJ offers broader diversification with 110 holdings and a lower 0.40% expense ratio, while PJP's concentrated U.S. pharma strategy delivered a 44.90% one-year return.
IHE vs IXJ: Which Popular Healthcare ETF Is the Better Buy for Investors?
08:16pm, Saturday, 18'th Jul 2026
iShares Global Healthcare ETF provides exposure to 110 international stocks, whereas iShares U.S. Pharmaceuticals ETF concentrates on 56 domestic companies iShares U.S. Pharmaceuticals ETF has higher
IXJ vs. IBBQ: Global Healthcare vs. Biotech -- Which ETF Is the Better Buy?
06:48am, Saturday, 18'th Jul 2026
The Invesco Nasdaq Biotechnology ETF (IBBQ) carries a lower expense ratio than the iShares Global Healthcare ETF (IXJ). IXJ offers broad global exposure across the healthcare sector, while IBBQ is con
Healthcare Investing in 2026: iShares Global Healthcare ETF Outperforms Invesco Health Care ETF
09:31am, Thursday, 16'th Jul 2026
iShares Global Healthcare ETF offers a higher dividend yield and lower volatility than Invesco S&P 500 Equal Weight Health Care ETF. Invesco S&P 500 Equal Weight Health Care ETF assigns identical weig
Fidelity (FHLC) vs. iShares (IXJ): Which Healthcare ETF Delivers Better Value?
07:20am, Friday, 26'th Jun 2026
iShares Global Healthcare ETF provides exposure to international markets, while Fidelity MSCI Health Care Index ETF focuses exclusively on U.S.-based companies. Fidelity MSCI Health Care Index ETF mai
IXJ: Healthcare Sector Dashboard For June
04:46pm, Thursday, 18'th Jun 2026
Healthcare equipment appears undervalued, while life science tools show weak quality. iShares Global Healthcare ETF provides global healthcare exposure but has underperformed the U.S.-focused XLV both
U.S. Health Care Depth or Global Industry Reach? VHT vs. IXJ
03:08pm, Monday, 01'st Jun 2026
The Vanguard Health Care ETF (VHT) and the iShares Global Healthcare ETF (IXJ) both target health care stocks, but they are tailored to different investor needs. One emphasizes broad, low-cost U.S. ex
GLP-1 Drugs Powered IHE's Big Year. IXJ Is Playing a Longer Game.
11:17am, Wednesday, 27'th May 2026
A closer look at portfolio makeup, yield, and risk reveals what sets these two iShares healthcare funds apart for investors seeking sector exposure.
